AusHealth
AusHealth is a self-funded medical research charity with headquarters in Adelaide.
It was established in 1985 (then called Medvet) as the research commercialisation arm of the Royal Adelaide Hospital. Today, its sole shareholder is the Central Adelaide Local Health Network (CALHN).
Since its inception, AusHealth has contributed more than $50 million to Australian led research in disease therapies, AI-powered clinical solutions and novel healthcare technologies. As well as funding researchers, it dedicates itself to ‘translating’ great ideas into investment-ready entities, aiming to retain the commercial benefits of Australian ideas and grow the nation’s health tech sector.
AusHealth has two commercial arms: AusHealth Hospitals (which provides revenue management services to the healthcare sector); and AusHealth Diagnostics (Australia’s largest provider of workplace drug and alcohol testing). The organisation employs around 300 people, delivering services across all states and territories.
All proceeds from AusHealth’s commercial enterprises go towards more than a dozen medical research endeavours.
These projects are collectively managed by AusHealth Ventures, which operates out of a new research hub called The Accelerator, where entrepreneurs, innovators and health tech specialists collaborate. The bricks and mortar hub is located in Underdale, Adelaide; it opened in 2024.
Our Network
AusHealth employs more than 300 people. It has offices in Adelaide, Melbourne and Brisbane; it also has a network of collectors who conduct workplace safety tests right across the country.
AusHealth National Office
65 Hardys Rd, Underdale,
South Australia 5032
Our Offices
Victoria
35 Elizabeth Street,
Richmond VIC 3121
Queensland
Level 2, 348 Edward Street,
Brisbane City QLD 4000
Northern Territory
Level 16, 19 Smith Street The Mall,
Darwin City NT 0800
Western Australia
Level 13 37 St Georges Terrace,
Perth WA 6000
Our Policies
AusHealth has a range of policies relating to privacy, quality, safety, environment, diversity, modern slavery and business continuity. To obtain the latest version of any AusHealth policy, please contact Compliance Manager Jyoti Chatta at jchatta@aushealth.com.au
Our Accreditations and Certifications
We are certified by a number of independent bodies – including the National Association of Testing Authorities (NATA) (Accreditation No. 15338, Site No. 16007), Total Quality Certification Services International (TQCSI) for ISO 45001:2018, Safety Management System and ISO 9001: 2015, Quality Management System, and a member of the Healthcare Financial Management Association (HFMA).
We are frequently audited to ensure we deliver the best services to Australian organisations.
Our Board
Dr Deborah Cole
CHAIRPERSON
Deborah is a pioneer of value-based health care (VBHC) in the Australian health system. She has held CEO positions at Dental Health Services Victoria, Calvary Health Care ACT and Yarra City Council, and senior executive positions at Mercy Health and St Vincent’s Health. She is currently a Non-Executive Director of Western Health and Frontier Advisors. Her previous board roles included HESTA, Australian Healthcare and Hospitals Association, HumanAbility and Hessel Care Foundation.
Ms Jenny Paradiso
Jenny co-founded Suntrix, a national solar and battery storage company; she was Managing Director from 2009 to 2024. Jenny has worked on numerous boards and advisory groups. She has also mentored business owners and coached women in their professional development through Behind Closed Doors and the CEC Women In Renewables program.
Professor Andrew Zannettino
Andrew is Executive Director of Research Strategy for CALHN and Pro Vice Chancellor of Health Partnerships at the University of Adelaide. At the university, he also heads the Myeloma Research Laboratory and co-heads the Regenerative Medicine Program (RMP). The RMP stems from collaborative studies in association with Prof Stan Gronthos and Prof Paul Simmons, which in turn led to a family of eight patents underpinning the world’s largest cell therapy company, Mesoblast.
Prof Guy Ludbrook
Professor Ludbrook is Professor of Anaesthesia at the University of Adelaide and Royal Adelaide Hospital. His expertise is in health systems, health services, health economics, anaesthesia, medical devices and clinical trials (phase 1 to phase 3). He is Director of an early phase clinical trials unit, PARC Clinical Research, located within the Royal Adelaide Hospital. He is increasingly involved in health services review to optimise value in healthcare, and in the design and the study of new systems of care.
Dr Stephen Livesey
Stephen Livesey has a professional background in medicine, medical research and commercialisation. He is the co-founder of LifeCell Corporation in the United States and has held executive and board positions at the Australian Stem Cell Centre, CRC for Cell Therapy Manufacturing, BioVictus, CureCell, TekCyte and Carina Biotech. He has also worked as a scientist for Clinical Neurosciences SVHM.
Roseanne Healy
Roseanne is a professional non-executive director with over 30 years of leadership experience in legal, risk, finance and corporate governance. She serves as the Managing Director of Enterprise Corporation, a boutique corporate advisory and private equity firm; she also chairs Mayfield Childcare and VeroGuard System and is a non-executive director on the Murray Darling Basin Authority and Australian Grain Technologies.